BlueGenes, a leading pharmacogenetics solution, and Levrx Technology, a digital pharmacy engagement platform, have announced a strategic partnership. Together they aim to accelerate the adoption of personalized prescribing by seamlessly integrating genetic testing insights into pharmacy benefit systems.
Each year, adverse drug reactions cause more than 100,000 deaths in the U.S. – BlueGenes aims to reduce that number by 50%. While PGX insights help guide safer prescribing, adoption has historically lagged. BlueGenes and Levrx are working together to change that.
Health Technology Insights: Daewoong Launches NABOTA in Qatar, Eyes GCC Market Growth
BlueGenes identifies genetic risks and safer alternatives during claims processing, and Levrx brings those insights forward through its trusted digital platform—helping patients get to the right therapy faster and act with confidence.
“We’re making precision medicine practical,” said Nick Glimcher, CEO of BlueGenes. “Our solution identifies what needs to be done. Levrx makes sure it reaches the patient.”
“BlueGenes brings the science. Levrx makes it actionable,” said Vikram Agrawal, CEO of Levrx. “It’s about delivering the right insight at the right time, in the experience patients already trust—so they can take the right next step.”
Health Technology Insights: Holy Family Hospital Staff Unionize with MNA for Better Care and Respect
The combined solution doesn’t add another platform—it strengthens the one patients already rely on to make pharmacy decisions. Levrx is the front door to the benefit experience. Now, with BlueGenes, it delivers advanced clinical insight as part of that same journey.
“We built Levrx to simplify decision-making,” said Vikash Agrawal, Executive Chairman at Levrx. “This collaboration helps patients make smarter, safer choices right when they need to—not after the fact and not buried in paperwork.”
As personalized healthcare continues to evolve, partnerships like this one between BlueGenes and Levrx signal a shift from passive data collection to proactive decision-making, paving the way for a new standard in medication safety.
Health Technology Insights: BUDS Technology Transforms Senior Care with AKSSI Virtual Nurse Assistant
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – GlobeNewswire
